Finance ❯ Corporate Finance ❯ Mergers and Acquisitions ❯ Valuation

Investment

Pfizer Closes Metsera Buyout, Adding GLP-1 Assets in Cash-Plus-CVR Deal

The cash-plus-CVR deal followed FTC concerns over Novo Nordisk’s bid, setting expectations for near-term dilution.

Wojcicki’s Nonprofit Tops Regeneron With $305M Bid for 23andMe